Literature DB >> 4595955

Impaired immunoresponsiveness in tumor patients.

J Harris, D Copeland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4595955     DOI： 10.1111/j.1749-6632.1974.tb14437.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  10 in total

1.  Chronic lymphocytic leukemia.

Authors:  D W Martin; R C Siegel; L H Smith
Journal:  West J Med       Date:  1977-09

2.  Vincristine infusion. A phase I study.

Authors:  W Weber; G A Nagel; E Nagel-Studer; R Albrecht
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

3.  Corticosteroids decrease the expression of beta 2-microglobulin and histocompatibility antigens on human peripheral blood lymphocytes in vitro.

Authors:  M Hokland; B Larsen; I Heron; T Plesner
Journal:  Clin Exp Immunol       Date:  1981-05       Impact factor: 4.330

Review 4.  [Pathogenesis and therapy of malnutrition in oncology].

Authors:  G Ollenschläger
Journal:  Z Ernahrungswiss       Date:  1982-06

5.  Modification of lymphocyte response to phytomitogens by polycations and polyanions.

Authors:  B Larsen; I Heron
Journal:  Experientia       Date:  1978-09-15

6.  Changes of lymphocyte subsets in peripheral blood before and after operation of patients with advanced ovarian carcinoma.

Authors:  Y Kikuchi; I Iwano; T Kita; M Miyauchi; E Kuki; K Oomori; I Nagata
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

7.  Correlation if circulating immune complexes and disease status in patients with leukaemia.

Authors:  R A Hubbard; M C Aggio; B B Lozzio; C J Wust
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

8.  Reduced monocyte phagocytosis in patients with advanced Hodgkin's disease and lymphosarcoma.

Authors:  D Urbanitz; I Fechner; R Gross
Journal:  Klin Wochenschr       Date:  1975-05-01

9.  Quantitation of T- and B-lymphocytes in peripheral blood of patients with solid tumours. I. Relation to other parameters of in vivo and in vitro immune competence.

Authors:  J Harris; T Stewart; D P Sengar; D Hyslop
Journal:  Can Med Assoc J       Date:  1975-04-19       Impact factor: 8.262

10.  Cellular immunocompetence in melanoma: effect of extent of disease and immunotherapy.

Authors:  V K Lui; J Karpuchas; P B Dent; P B McCulloch; M A Blajchman
Journal:  Br J Cancer       Date:  1975-09       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.